IPCA Laboratories Limited — Updates, 09-02-2026: General Updates
09-02-2026 | 05:14 pm
09-02-2026 | 05:14 pm
Ipca Lab has commenced commercial production at its new greenfield Drug Intermediates/API manufacturing facility. Built with a capital outlay of 182 Cr, this operational expansion aims to boost future production and revenue.
No comments yet. Be the first to comment!
